DSAM Partners’s Elevance Health ELV Stock Holding History

DSAM Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-37,707	Closed	-$8.56M	–	39
2020 Q1	$8.56M	Buy	+37,707	New	+$10.3M	2.02%	19
2019 Q3	–	Sell	-52,845	Closed	-$14.9M	–	86
2019 Q2	$14.9M	Buy	52,845 +17,945	+51%	+$4.9M	1.85%	24
2019 Q1	$10M	Sell	34,900 -93,258	-73%	-$27M	1.45%	25
2018 Q4	$33.7M	Buy	128,158 +16,611	+15%	+$4.57M	7%	4
2018 Q3	$30.6M	Buy	111,547 +66,619	+148%	+$17.3M	4.48%	4
2018 Q2	$10.7M	Buy	44,928 +3,820	+9%	+$885K	2.15%	18
2018 Q1	$9.03M	Sell	41,108 -86,448	-68%	-$20.3M	1.53%	26
2017 Q4	$28.7M	Buy	127,556 +55,402	+77%	+$11.8M	4.83%	8
2017 Q3	$13.7M	Sell	72,154 -171,348	-70%	-$32.6M	1.91%	26
2017 Q2	$45.8M	Sell	243,502 -104,742	-30%	-$18.8M	8.15%	1
2017 Q1	$57.6M	Buy	+348,244	New	+$55.4M	12.55%	1

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DSAM Partners's ELV Position: Q2 2020 in Review

DSAM Partners sold out of Elevance Health (ELV) in Q2 2020, closing a stake of 37,707 shares — an estimated $8.56M sold.

DSAM Partners first reported a position in ELV in Q1 2017 and held it in 11 quarters. The position peaked at $57.6M in Q1 2017. 1,107 funds tracked by Wall St. Rank hold ELV as of Q2 2020.

DSAM Partners reported no remaining Elevance Health position as of Q2 2020 after selling out during the quarter.
DSAM Partners sold 37,707 Elevance Health shares in Q2 2020, an estimated $8.56M.
DSAM Partners first reported a position in Elevance Health in Q1 2017 and held it in 11 quarters.
DSAM Partners's Elevance Health position peaked at $57.6M in Q1 2017.
1,107 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.

Based on DSAM Partners's 13F filing for Q2 2020, filed 14 Aug 2020.